Genomic blood test predicts survival rates after surgery for advanced heart failure

(University of California - Los Angeles Health Sciences) An experimental blood test developed at UCLA that uses gene activity data from immune cells was 93 percent accurate in predicting survival rates for people with advanced heart failure who had surgery to implant mechanical circulatory support devices.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news